Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-002173
Filing Date
2025-06-17
Accepted
2025-06-17 17:54:43
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3758
2 shacham_poa.htm EX-24 11886
  Complete submission text file 0000905148-25-002173.txt   17031
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Shacham Sharon (Reporting) CIK: 0001588438 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41551 | Film No.: 251054526

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)